Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
2.140
+0.160 (8.08%)
At close: Jan 21, 2025, 4:00 PM
2.170
+0.030 (1.41%)
After-hours: Jan 21, 2025, 7:25 PM EST
Milestone Pharmaceuticals Employees
Milestone Pharmaceuticals had 47 employees as of December 31, 2023. The number of employees increased by 8 or 20.51% compared to the previous year.
Employees
47
Change (1Y)
8
Growth (1Y)
20.51%
Revenue / Employee
n/a
Profits / Employee
-$909,936
Market Cap
141.75M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
MIST News
- 14 days ago - Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update - GlobeNewsWire
- 4 months ago - Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China - GlobeNewsWire
- 4 months ago - Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors - GlobeNewsWire
- 5 months ago - Milestone Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Regulatory and Corporate Update - GlobeNewsWire
- 7 months ago - Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspectives on PSVT in the Community Setting” on June 20, 2024 - GlobeNewsWire
- 8 months ago - Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference - GlobeNewsWire
- 8 months ago - Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™ - GlobeNewsWire